Method and construct for inhibition of cell migration
CA 2289117 A1 · Owner: Quax, Paulus Hubertus Andreas · Inventors: Quax, Paulus Hubertus Andreas; Verheijen, Johan Hendrikus
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A recombinant nucleic acid molecule comprising a vector useful for transfection or transduction of mammalian cells wherein said vector contains , a nucleic acid insertion encoding an expressible hybrid polypeptide or protein which comprises a domain with a binding function and a domain with an effector function. The domain with a binding function may comprise a receptor binding domain, and the domain with an effector function may have enzymatic activity in particular protease inhibitor activity. The vector may be a viral (e.g. adenovirus or retrovirus) or non-viral vector useful for transfection or transduction of mammalian cells. The nucleic acid insertion encoding an expressible …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 11, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 11, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 11, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.